Gelpi Ricardo J, Morales Celina, Cohen Michael V, Downey James M
Department of Pathology, Faculty of Medicine, University of Buenos Aires, Argentina.
Basic Res Cardiol. 2002 Jan;97(1):40-6. doi: 10.1007/s395-002-8386-0.
Studies of preconditioning frequently use the isolated rat heart model in which recovery of post-ischemic function is the end-point. However, function following an episode of ischemia/reperfusion represents a composite of both stunning, which is related to free radical production and is not attenuated by preconditioning, and tissue salvage, the primary effect of preconditioning. Brief ischemia/reperfusion is also known to diminish adenosine release during subsequent ischemia by a mechanism independent of preconditioning's anti-infarct effect. Reduced purine release would diminish generation of free radicals by xanthine oxidase in rat heart and thus produce less stunning. In this paradigm preserved post-ischemic function in rat heart might look similar to salvage by preconditioning, but its mechanism would be quite different and not be relevant to the xanthine oxidase-deficient human heart. This hypothesis was tested in isolated rat hearts. Control or ischemically preconditioned hearts were subjected to 30 min of global ischemia and 60 min of reperfusion, either in the presence or absence of 25 micromol/l allopurinol, an inhibitor of xanthine oxidase. In non-preconditioned hearts allopurinol increased left ventricular developed pressure after 60 min of reperfusion from 26 +/- 5 mmHg in control hearts to 47 +/- 7 mmHg, whereas developed pressure in preconditioned hearts following reperfusion was 59 +/- 5 mmHg and was unaffected by allopurinol. Developed pressure in non-preconditioned hearts treated with allopurinol was midway between that for untreated control and preconditioned hearts suggesting that at least 50% of the recovery of developed pressure in preconditioned hearts may be related to free radical-induced stunning. In xanthine oxidase-deficient rabbit hearts, return of function was not different between non-preconditioned and preconditioned hearts. Therefore, post-ischemic developed pressure in the rat is significantly affected by purine-dependent stunning, and, hence, may be an unreliable marker of tissue salvage and also a poor index of what might be cardioprotective in man.
预处理研究经常使用离体大鼠心脏模型,该模型以缺血后功能恢复作为终点。然而,缺血/再灌注后的功能是由两种情况共同构成的,一种是心肌顿抑,它与自由基产生有关且不受预处理的影响,另一种是组织挽救,这是预处理的主要作用。短暂的缺血/再灌注还已知会通过一种独立于预处理抗梗死效应的机制减少后续缺血期间的腺苷释放。嘌呤释放减少会减少大鼠心脏中黄嘌呤氧化酶产生的自由基,从而产生较少的心肌顿抑。在这种模式下,大鼠心脏缺血后保留的功能可能看起来与预处理的挽救作用相似,但其机制会大不相同,且与黄嘌呤氧化酶缺陷的人类心脏无关。该假设在离体大鼠心脏中进行了验证。对照或经缺血预处理的心脏接受30分钟全心缺血和60分钟再灌注,分别在存在或不存在25微摩尔/升别嘌呤醇(一种黄嘌呤氧化酶抑制剂)的情况下进行。在未预处理的心脏中,再灌注60分钟后别嘌呤醇使左心室舒张末压从对照心脏的26±5毫米汞柱增加到47±7毫米汞柱,而预处理心脏再灌注后的舒张末压为59±5毫米汞柱且不受别嘌呤醇影响。用别嘌呤醇处理的未预处理心脏的舒张末压处于未处理对照心脏和预处理心脏之间,这表明预处理心脏中至少50%的舒张末压恢复可能与自由基诱导的心肌顿抑有关。在黄嘌呤氧化酶缺陷的兔心脏中,未预处理和预处理心脏之间的功能恢复没有差异。因此,大鼠缺血后的舒张末压受嘌呤依赖性心肌顿抑的显著影响,因此可能是组织挽救的不可靠标志物,也是对人类心脏保护作用的不良指标。